v3.23.3
Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]            
Federal grants $ 435,380 $ 279,351 $ 1,715,488 $ 1,089,920 $ 2,523,383 $ 3,531,199
Operating expenses:            
Research and development 1,914,970 4,756,096 5,354,713 13,393,948 19,835,875 4,690,082
General and administrative 1,227,724 1,686,580 3,923,277 5,717,281 6,909,603 18,711,548
Total operating expenses 3,142,694 6,442,676 9,277,990 19,111,229 26,745,478 23,401,630
Loss from operations (2,707,314) (6,163,325) (7,562,502) (18,021,309) (24,222,095) (19,870,431)
Other income (expense):            
Change in fair value of derivative liabilities         673,314
Loss on issuance of convertible notes (3,609,944) (3,609,944) (3,609,944)
Issuance costs for convertible notes (1,118,721) (1,118,721) (1,137,740) (1,920,158)
Change in fair value of convertible notes 3,491,513 146,479 6,169,929 5,756,787 (2,993,060)
Issuance of liability classified warrants (3,737,371) (3,737,371) (3,737,371) (1,865,403)
Change in fair value of liability classified warrants 17,223 2,683,340 279,873 5,626,130 6,730,613 (1,438,186)
Loss on debt conversions (1,404,877) (4,000,155) (3,964,633) (154,391)
Interest expense, net (7,649) (4,859) (9,146) (57,662) (109,525) (1,295,307)
Other income, net 6,934 8,679 23,382 19,494 86,223 (282,279)
Total other income (expense), net 16,508 (3,692,240) 440,588 (708,300) 14,410 (9,275,470)
Net loss (2,690,806) (9,855,565) (7,121,914) (18,729,609) (24,207,685) (29,145,901)
Net loss attributable to noncontrolling interests (1,235) (21,492) (12,236) (47,619) (35,393) (62,190)
Deemed dividend related to warrants down round provision 63,539 12,038 881,598 913,204 803,140
Net loss attributable to common stockholders $ (2,689,571) $ (9,897,612) $ (7,121,716) $ (19,563,588) $ (25,085,496) $ (29,886,851)
Net loss per basic and diluted share:            
Net loss per share attributable to common stockholders, basic $ (0.87) $ (61.58) $ (3.32) $ (140.90) $ (139.42) $ (355.72)
Weighted average common shares outstanding, basic 3,085,873 160,719 2,145,505 138,849 179,925 84,018
Net loss per share attributable to common stockholders, diluted $ (0.87) $ (61.58) $ (3.32) $ (140.90)    
Weighted average common shares outstanding, diluted 3,085,873 160,719 2,145,505 138,849